Emovate, Crème

7680431420016 CH-43142 Crème

Associated product:

EMOVATE crème tb 30 g
Emovate, Crème
Emovate, Crème
Emovate, Crème
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
g
Galenic form
Crème
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
48.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 12.60
Specialties list
Yes
Generic
No
SL addition date: 01/04/2016

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
43142
Drug name
Emovate, Crème
Galenic form
CREM
ATC Code
D07AB01
Authorization status
Z
Dispensing category
B
First authorization
25/08/1980
Authorization expiration date
31/12/9999
IT Number
10.05.1.
Domain
Human medicine
Field of application
Entzündliche, nicht infizierte Dermatosen

Package details

Description (FR)
EMOVATE crème tb 30 g
Description (DE)
EMOVATE Creme Tb 30 g
Market launch
25/08/1980
Narcotic (BTM)
No

Other package sizes (2)

EMOVATE crème 25 g
None None
GTIN: 7680431420115
Not in V1
EMOVATE crème 100 g
None None
GTIN: 7680431420382
Not in V1